When blood sugar starts to rise after a person eats, GLP-1 agonists cause the body to make more insulin. This extra insulin ...
Novo Nordisk (NVO) has received approval to market its oral GLP-1 medicine Rybelsus in the U.S. to reduce the risk of major ...
Back in May, a study was published suggesting that popular weight-loss drugs such as Ozempic and Wegovy could curb alcohol cravings by as much as 70%. At the time, researchers weren't entirely sure ...